logo-loader
viewExactus, Inc

Exactus Inc 'targeting the highest-growth segments of the CBD market'

Proactive Research analyst Emma Ulker says Exactus Inc (OTCMKTS:EXDI) is an early mover in the hemp-derived cannabinoids market and has ambitions to carve out a leading position in the field.

Ulker says EXDI is preparing to launch a range of branded products by means of its scaleable cultivation and production platforms including CBD-infused tinctures, soft gel capsules, topical cosmetics and body care products.

Quick facts: Exactus, Inc

Price: 0.59 USD

OTCMKTS:EXDI
Market: OTCMKTS
Market Cap: $20.61 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Exactus, Inc named herein, including the promotion by the Company of Exactus, Inc in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Enteq Upstream PLC's international strategy 'delivering real results'

Proactive Research analyst Ed Stacey gives his view on Enteq Upstream PLC's (LON:NTQ) interim results to September 2019 which saw revenues increasing 58% and adjusted underlying earnings (EBITDA) up 143% year-on-year. Stacey says major new customer wins in China reflect the company's...

1 day, 9 hours ago

2 min read